Michael R Landauer
Overview
Explore the profile of Michael R Landauer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
630
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Davis T, Landauer M, Mog S, Barshishat-Kupper M, Zins S, Amare M, et al.
Exp Hematol
. 2010 Feb;
38(4):270-81.
PMID: 20116413
Objective: Angiotensin II (Ang II), a potent vasoconstrictor, affects the growth and development of hematopoietic cells. Mixed findings have been reported for the effects of angiotensin-converting enzyme (ACE) inhibitors on...
12.
Singh V, Grace M, Parekh V, Whitnall M, Landauer M
Int Immunopharmacol
. 2009 Sep;
9(12):1401-10.
PMID: 19716438
The development of an effective pharmacological countermeasure is needed to reduce the morbidity and mortality in military and civilian populations associated with possible exposure to ionizing radiation. We previously demonstrated...
13.
Weiss J, Landauer M
Int J Radiat Biol
. 2009 Jun;
85(7):539-73.
PMID: 19557599
Purpose: The search for ideal protective agents for use in a variety of radiation scenarios has continued for more than six decades. This review evaluates agents and procedures that have...
14.
Davis T, Mungunsukh O, Zins S, Day R, Landauer M
Int J Radiat Biol
. 2008 Sep;
84(9):713-26.
PMID: 18821385
Purpose: In this study we addressed whether genistein-induced radioprotection in mice is associated with alterations of the cell cycle of hematopoietic stem and progenitor cells. Materials And Methods: C57BL/6J female...
15.
Day R, Barshishat-Kupper M, Mog S, McCart E, Prasanna P, Davis T, et al.
J Radiat Res
. 2008 Apr;
49(4):361-72.
PMID: 18434686
The effects of genistein on 30-day survival and delayed lung injury were examined in C57BL/6J female mice. A single subcutaneous injection of vehicle (PEG-400) or genistein (200 mg/kg) was administered...
16.
Davis T, Clarke T, Mog S, Landauer M
Int J Radiat Biol
. 2007 Mar;
83(3):141-51.
PMID: 17378522
Purpose: Genistein, a non-toxic isoflavone from soybeans, has immunomodulating and radioprotective properties. In this study we investigated the mechanism for genistein-induced radioprotection by evaluating the recovery of bone marrow cells...
17.
Hong H, Landauer M, Foriska M, Ledney G
J Basic Microbiol
. 2006 Jul;
46(4):329-35.
PMID: 16847837
Genistein, a radioprotective soy isoflavone and protein kinase inhibitor, blocks the invasion of pathogenic bacteria in mammalian epithelial cells. The purpose of this study was to evaluate the direct effect...
18.
Landauer M, Srinivasan V, Seed T
J Appl Toxicol
. 2003 Nov;
23(6):379-85.
PMID: 14635262
The radioprotective and behavioral effects of an acute administration of the isoflavone genistein (4',5,7-trihydroxyflavone) were investigated in adult CD2F1 male mice. Mice were administered a single subcutaneous (s.c.) dose of...
19.
Weiss J, Landauer M
Toxicology
. 2003 Jun;
189(1-2):1-20.
PMID: 12821279
The potential of antioxidants to reduce the cellular damage induced by ionizing radiation has been studied in animal models for more than 50 years. The application of antioxidant radioprotectors to...
20.
Knudson G, Elliott T, Brook I, Shoemaker M, Pastel R, Lowy R, et al.
Mil Med
. 2002 Mar;
167(2 Suppl):95-7.
PMID: 11873528
The Armed Forces Radiobiological Research Institute (AFRRI) has developed a research program to determine the major health risks from exposure to ionizing radiation in combination with biological and chemical warfare...